COVID-19 vaccine hesitancy in a tribal-state of India: A cross-sectional study Authors: Tanya Tanu, Dewesh Kumar, Mithilesh Kumar, Vidya Sagar, Prerna Anand, Ravi R. Jha, Rishabh K. Rana, Sahil N. Rajnish, Apoorva Wasnik, N. Venkatesh Published: 2025 ABSTRACT ABSTRACTBackground:The delayed acceptance or abject refusal to take vaccines despite the availability of vaccination services has been termed as vaccine hesitancy (VH). The 5C Model of VH includes Confidence, Convenience, Complacency, and Communication as major determinants of VH in the population.Materials and Methods:This study was conducted among vaccinees enrolled at the Vaccination Center of the largest tertiary hospital in the tribal state of Jharkhand. The study was a cross-sectional study aimed to determine the extent of VH for COVID-19 vaccines prevalent in the study population and the associated factors. The study subjects included vaccinees at RIMS, Ranchi Vaccination Center. It included all subjects aged 18 years and above, consenting to be a part of the study. Study participants were recruited from the line list prepared for COVID-19 vaccination from the Co-win portal. A total of 625 participants were recruited. A predesigned, pretested, semistructured questionnaire was administered to all the study participants.Results:Out of the 625 recruited participants, VH was found in 165 subjects. The factor that is the biggest contributor to VH was the fear of the potential long-/short-term side effects of the vaccine (31.7%), which was followed by the fear of the pain from the shot (14.9%) and distrust in the vaccines due to shorter clinical trials (14.9%).Conclusion:V is a significant, living phenomenon that is translating into geographical clustering of epidemics and requires attention on both the micro- and macrolevels to be addressed successfully. Introduction The contemporary world has seen a rise in the incidence of disease outbreaks, epidemics, and pandemics. The most important cause behind this shift in disease transmission pattern has been the gradual transition of man from a hunter-gatherer to being part of an agrarian society.[1] Changing ecosystems due to increased population and human behavior has led to the emergence in the incidence of pandemics, infectious and noninfectious alike.[2] While massive efforts are being made to eradicate certain diseases, the global public health community is also facing the brunt of increased incidence of noncommunicable diseases such as hypertension, diabetes, ischemic heart diseases, and obesity.[3] In addition, there has been a rise in epidemics that are particularly infectious in origin with viruses being the leading cause.[4] COVID-19 was a zoonotic disease that spread as a result of cross-species transmission.[5] The causative agent was found to be the SARS-CoV2 virus belonging to the family Coronaviridae.[6] The animal reservoirs of the disease were bats and Pangolins were the hosts.[7] The symptoms mainly consisted of fever, dry cough, fatigue, myalgia, nausea, diarrhoea, anosmia, ageusia, and shortness of breath. The presence of comorbidities such as diabetes, hypertension, malignancies, etc., further complicated the disease.[8] The global case fatality was found to be 0.25–3%.[9] The mortality trends were age-specific ranging from 0.02% in patients aged 20–49 years and 0.5% in those aged 50–69 years and to as high as 5.4% in patients in the age group of more than 80 years.[10] As the pandemic progressed, countries all over the world began funding pharmaceutical industries to devise efficient vaccines against COVID-19. Globally, the COVID-19 vaccine acceptance rates ranged from 17.5% to 82.6%.[11] A major hurdle in the road to unhampered immunization across the world, including India, has been the phenomenon of vaccine hesitancy (VH). VH has been defined by the World Health Organization (WHO) as a “delay in acceptance or refusal of vaccines despite availability of vaccination services.”[12] According to a systematic review and meta-analysis done by Fajar et al.,[13] the global prevalence of VH was found to be 25%. VH outbreak is a potential disaster that is just lurking around the corner, ready to pounce. Such is the impact of VH on our health system, that the WHO has declared it as one of the ten biggest threats to global health.[14] In community settings where family physicians and primary care providers serve as highly trusted allies for dissemination of health information, VH poses a significant threat to attainment of primary care goals. Vaccine uptake is influenced by complex and multifaceted drivers including distrust, myths, and cultural backgrounds along with amplified concerns about vaccine safety often spread through misinformation via social media. The present study on revolves around understanding the COVID-19 vaccine uptake, acceptance, and hesitancy in a Tribal State of India and aims to determine the prevalence of VH among vaccinees presenting at the vaccination center of a tertiary-level hospital in the tribal state of Jharkhand, India where little/no such research on VH has been done in the past, especially in the context with Doctors. Doctors and Health Professionals are deeply embedded in the social fabric, thereby significantly influencing vaccine-seeking behavior. The study shall prove dynamic in addressing the issues related to mass immunization against COVID-19 and thereby combating it. Material and Methods Study Design: This was a cross-sectional study conducted between August 2021 and January 2022 at the Cowin Vaccination Center of Rajendra Institute of Medical Sciences (RIMS), Ranchi, the largest tertiary care hospital in the tribal state of Jharkhand, India. Study Participants: Respondents included all adults above 18 years of age who consented to be part of the study, including both Healthcare and nonhealthcare workers, enrolled in the Cowin Portal of the COVID-19 Vaccination Center of the hospital.[14] The inclusion criteria consisted of all vaccinees aged 18 years and above, enrolled in the Cowin portal who consented to be a part of the study. All such vaccinees formed the target population out of which people who consented to be a part of the study were randomly chosen as study subjects. Two groups were allocated, the first group consisted of the healthcare workers and staff and the second group consisted of the nonhealthcare workers, and a comparative study between the two groups was done. Since the study on VH due to COVID-19 vaccines is a relatively new subject, especially in the state of Jharkhand, not much information regarding the prevalence of VH toward COVID-19 vaccines could be gathered. Hence, as a result of limited information in this area, we assumed that 50% of the population under study was vaccine-hesitant, which gave us maximum variability. Taking a precision value of 4%, we computed a final sample size of 600 participants. However, we collected data from 660 subjects to make up for inadequate responses and missing data, out of which 625 were considered for data analysis after data cleaning. Study Instruments: A predesigned, semistructured questionnaire was developed to collect data from all people presenting at the Covid Vaccination Center, RIMS, Ranchi, as per the objectives and under the guidance of faculties. The semistructured questionnaire was pretested by conducting a pilot study among 15 subjects and necessary modifications were made accordingly. Informed consent was taken from the study subjects in Hindi or English language, depending on their convenience. The questionnaire had two components: the sociodemographic profile and vaccine seeking behavior of the study participants. Data Collection: Data were collected by interview method using the pretested questionnaire. There were separate queues for healthcare workers and nonhealthcare workers, which were again divided into queues for senior citizens, women, and men. The participants were approached once they were verified for vaccination on the Cowin portal. In case the selected participant did not report to the vaccination centre on the given date, he/she was contacted and after appropriately understanding the reason for nonreporting he/she was either registered for vaccination on another date or home-based visits were done and the questionnaire administered. In case home-based visits were done, interviews of the other family members were also taken. Ethical approval for the study was obtained from the Institutional Ethics Committee of RIMS, Ranchi. Data entry was done in MS Excel. Template was generated in MS Excel and data analysis was done using the latest version of SPSS software. Data were expressed in percentages and proportions. Chi-square tests were applied to note the association and further analysis was done using multivariate logistic regression. A P value less than 0.05 was considered to be significant. Statistics: After cleaning and coding, the processed data were transferred to IBM SPSS software for Windows, version 20 from MS Excel, for analysis. Means and percentages were used to summarize numerical data. Categorical data were collected. Frequency and proportions were used to summarize the data. Relationships between independent factors and dependent variables were determined using the Chi-square test or Fisher’s exact test, and logistic regression analysis was used to evaluate variables. P < 0.05 was considered statistically significant. Ethical Considerations: The study was approved by the Institutional Ethical Committee of the institution of origin of this study. Informed consent was obtained from all participants before data collection. Adequate privacy was provided during the interviews and the details of the participants were maintained in strict confidentiality. Results Basic demographics A total of 625 participants were recruited for the study, of which 466 (74.6%) were healthcare workers and 159 (25.4%) were nonhealthcare workers. As the study participants were drawn from the Cowin portal, all 625 participants had received at least 1 dose of the COVID-19 vaccine. The majority of the study subjects belonged to the age group of 20–30 years (72.80%). A greater section of the study participants were females (58.72%). About 78.4% of the subjects were Hindus. 17.4% of the study participants belonged to the tribal population. As a majority of the study subjects were students of the Medical College, a significant proportion of them contributed toward the unemployed section of the study subjects (53.4%). A majority of the study participants were students (53%). 24.8% of the study participants were working in the private sector, while 19.4% of the study participants were employed in government jobs. About 2.9% of the study participants were self-employed. 76% of the study participants had nuclear families. About 82.4% of the study participants lived in urban areas and 77% of the study participants were unmarried. A majority of the study subjects were graduates (39.8%). Heads of the families of a major section of the study participants had government jobs (48.3%) and were graduates (39.8%). The majority of the Heads of Families of the study participants were in government jobs (48.3%) and were graduates (45.9%). According to the Modified BG Prasad Scale, 70.9% of the study population belonged to the upper class [Table 1]. Table 1Association of demographic characteristics and vaccine hesitancySociodemographic factors (n=625)FrequencyPercentage (%) P χ 2 18–20294.640.2351.24420–3045572.830–409314.8840–50304.850–60142.2460–7030.4870–8010.16Female36758.720.2881.127Male25841.28Atheist10.20.9232.56Buddhist30.5Christian589.3Hindu49078.4Jain20.3Muslim406.4Sarna284.5Sikh30.5General33052.80.7411.248OBC14222.7Scheduled Caste457.2Scheduled Tribe10817.3Employed29146.60.7690.086Unemployed33453.4No15925.40.2421.371Yes46674.6Joint150240.5590.341Nuclear47576Rural11017.60.3020.583Urban51582.4Married14222.70.8011.002Separated10.2Unmarried48177Widowed10.2Diploma50.88.1330.321Graduate24939.8High School Certificate8113Illiterate10.2Intermediate18129Middle School Certificate61Primary School Certificate20.3Profession or Honors10016Class I (Upper Class)44370.90.02910.805Class II (Upper Middle Class)8213.1Class III (Middle Class)233.7Class IV (Lower Middle Class)579.1Class V (Lower Class)203.2The Chi-square statistic is significant at the 0.05 level Association of demographic characteristics and vaccine hesitancy The Chi-square statistic is significant at the 0.05 level Awareness and attitudes regarding COVID-19 and COVID-19 vaccination status A brief overview of the awareness regarding COVID-19 vaccination among the study participants (n = 625) showed that 53.6% of the study participants did not believe that flu vaccines could be protective against COVID-19 [Table 2]. Table 2Awareness, perceptions, and attitudes associated with COVID-19 and COVID-19 vaccination status (n=625)Awareness, perceptions, and attitudes associated with COVID-19 and COVID-19 vaccination statusVariablesFrequencyPercentage (%)Do you think flu vaccines (influenza vaccines) are protective against COVID-19?No43569.6Yes19030.4Which group/groups do you think are eligible to take the vaccines?Adolescents52323.8Elderly49122.3Healthy Adults57126None of these100.5People with comorbidities26612.1Pregnant and Lactating women22310.1Under 5 Children1145.2Which group/groups do you think should absolutely refrain from taking the vaccine?Adolescents161.6Elderly363.6Healthy Adults181.8None of these868.5People with comorbidities19419.3Pregnant and Lactating women27026.8Under 5 Children38738.4Under what circumstances would you avoid taking the vaccine?Allergies24914Asthma794.5Children724.1Chronic Kidney Diseases1468.2Cough804.5Elderly241.4Fever39222.1Hypertension1468.2Lactation1176.6Menses603.4Diabetes1468.2Personal Errands402.3Pregnancy19210.8Travel321.8Would you prefer single shot vaccine or one with booster shots?Booster shots vaccine28946.2Single shot vaccine33653.8Do you prefer a shorter duration between subsequent booster doses or longer?Longer27944.6Shorter34655.4Would you take the COVID-19 vaccine if it is not free?No12019.2Yes50580.8Do you have more confidence in international vaccines or domestic vaccines?Domestic46474.2International16125.8Would you be willing to take the vaccine intranasally?No35857.3Yes26742.7What is the maximum amount of time you would be able or willing to spend to get a vaccinated?<1/2 hour27046.21–2 hours24742.32–3 hours345.83–4 hours335.7Have you received the vaccines proposed against COVID-19?Yes625100No00Are all your family members vaccinated against COVID-19?No487.7Yes57792.3How many doses of the vaccine against COVID-19 have you taken?1152.4244571.2316526.4Have you taken the booster dose against COVID-19?No40865.3Yes21734.7Delay in first/subsequent VaccinationNo54487Yes8113 Awareness, perceptions, and attitudes associated with COVID-19 and COVID-19 vaccination status (n=625) Around 46.2% of the study participants preferred single-shot vaccinations over precautionary doses; 19.2% confirmed they would not get vaccinated if the vaccine was not freely available; 74.2% of the study participants placed more confidence in home-grown vaccines over international ones. Since majority of the study participants stated fear of the shot as a contributor to VH, we tried to understand if they would prefer intranasal vaccines. We found that a staggering 42.7% showed positive vaccine-seeking behavior toward it. Around 52.3% of the study participants had received Covishield followed by Covaxin (45.3%) [Figure 1]. % Utilization of various vaccine candidates (N = 625) Covid-19 medical history and risk perception This section focused on the study subjects’ perception of the severity and risks associated with COVID-19 with structured questions such as previous history of contracting the disease or being a COVID-19 Long Hauler. Covid Long Haulers are people suffering from Long Covid after contracting the illness.[15] Other factors such as fear of a loved one contracting the illness and the overall trust in the government when it comes to prioritizing the health of the citizens during the COVID-19 pandemic were also evaluated. 32.6% of the study participants had a history of COVID-19 infection and 4.2% gave positive signs and symptoms with regards to Long Covid. Around 55.2% of the study participants confirmed experiencing side effects postvaccination [Table 3]. Table 3COVID-19 medical history and risk perception (n=625)COVID-19 medical history and risk perceptionVariablesFrequencyPercentage (%)Are you suffering from long COVID?No59995.8Yes264.2Were you ever diagnosed as COVID-19 positive?No42167.4Yes20432.6Are you worried that you or your loved ones will get sick from coronavirus, or that coronavirus will again overwhelm the healthcare system?No12319.7Yes50280.3Do you think that the government was prioritizing the health of its citizens during the pandemic?No9715.5Yes52884.5Did you ever have a side effect from the vaccine?No28044.8Yes34555.2 COVID-19 medical history and risk perception (n=625) VH and associated factors According to a modeling study by Watson et al. that aimed at assessing the effects of COVID-19 vaccination across 185 countries and territories, an estimated 19.8 million lives were saved leading to a reduction of COVID-19-related deaths by approximately 63%. Every 1% rise in vaccine skepticism can contribute to a 30% drop in vaccination coverage in an area.[161718] Since all our study participants had received at least 1 vaccine against COVID-19, we evaluated VH prevalence in the study population by directly asking the study participants if they were ever hesitant about taking the COVID-19 vaccines after deftly explaining to them the phenomenon of VH. The answers were recorded in either a “Yes” or “No,” with subjects who answered “Yes” being categorized in the Vaccine-Hesitant Population and the subjects who answered “No” as being categorized in the Non-Vaccine-Hesitant Population. The prevalence of VH in our study population was found to be 29.4%. 13% of our study participants said that there was a delay in the first/subsequent doses of the vaccines more than the stipulated time among them or their family members. Since the question on the factors that led to the delay in seeking vaccination among the study participants was multiple answer type, even though we had 81 study participants who said that there was a delayed vaccination, the factors that led to the delay had an n of 126 and the results were computed based on the same. According to our study, the factor that is the biggest contributor toward the delay was the fact that the family members had not reached the minimum age for vaccination (20.6%). This was followed by the fear of the potential long-/short-term side effects of the vaccine (9.5%). Adverse events following immunization (AEFI) were seen in 55% of the study participants. The main side effects encountered from the vaccines were pain at the site of injection, fever, headache, and body aches [Table 4]. A greater proportion of VH was found in nonhealthcare workers (29% of the total nonhealthcare workers) compared to healthcare workers (26.8% of the total healthcare workers) [Figure 2]. Table 4Vaccine-seeking behavior of the study participants (n=625)Vaccine seeking behaviorVariablesFrequencyPercentage (%)Vaccine hesitancyNo44170.6Yes18429.4Delay in first/subsequent vaccination in the study participants or their family membersNo54487Yes8113 Vaccine-seeking behavior of the study participants (n=625) Prevalence of vaccine hesitancy in healthcare workers and nonhealthcare workers (N = 625) Since the question on the factors that led to VH among the study participants was multiple answer type, even though we had 184 study participants who were found to be vaccine-hesitant, the factors that led to VH had an N of 350 and the results were computed based on the same. According to our study, the factor that is the biggest contributor to VH was the fear of the potential long-/short-term side effects of the vaccine (31.7%), which was followed by the fear of the pain from the shot (14.9%) and distrust in the vaccines due to shorter clinical trials (14.9%) [Figure 3]. Factors associated with vaccine hesitancy (multiple answer type questions) By univariate analysis [Table 5], the following factors were significantly associated with COVID-19 VH (P < 0.05): “Did you ever have a side effect from the vaccine?” (P = 0.000), “Was there a delay in taking subsequent doses more than the stipulated time?” (P = 0.000) and “Are all your family members vaccinated against COVID-19?” (P = 0.001). By multivariable analysis [Table 6], the following factors were significantly associated with COVID-19 VH (P < 0.0.05): “Did you ever have a side effect from the vaccine?” (P = 0.000), “Was there a delay in taking subsequent doses more than the stipulated time?” (P = 0.000). Table 5Predictors of COVID-19 vaccine hesitancy: a univariate analysis (n=625)Parameters (n=625)COVID-19 Vaccine HesitancyPearson Chi-square P ORCI 95%Did you or your family members ever have a side effect from any vaccine?Yes2.04(1.417–2.935)23.4380.00NoReferenceWas there a delay in getting vaccinated more than the stipulated time?Yes32.606(19.717–53.920)7.0390.00NoReferenceHave you taken the precautionary dose of the COVID-19 Vaccine?YesReference(0.623–1.371)0.1210.70No0.924Are you using masks in social settings and practicing COVID-19-appropriate behavior?Yes1.207(0.734–1.987)3.110.46NoReferenceAre you a healthcare worker or a medical student?No0.907(0.613–1.342)1.3710.63YesReferenceAre all your family members vaccinated against Covid-19?Yes0.433(0.239–0.784)1.6260.01NoReferenceOR=Odds Ratio, CI=Confidence Interval. P significant at <0.005 Predictors of COVID-19 vaccine hesitancy: a univariate analysis (n=625) OR=Odds Ratio, CI=Confidence Interval. P significant at <0.005 Table 6Predictors of COVID-19 vaccine hesitancy: A multivariate analysisPredictors of COVID-19 vaccine hesitancy95% C.I.ORAdjusted OR P LowerUpperDid you ever have a side effect from the vaccine?0.2910.6152.4430.4230Was there a delay in taking subsequent doses more than the stipulated time?0.2591.0691.90.5270.076Are you using masks in social settings and practicing COVID-19 COVID-19-appropriate behavior?0.9912.4340.6811.5530.055Are you a healthcare worker or a medical student?0.4911.1361.2740.7470.173Adjusted OR=Adjusted Odds Ratio, CI=Confidence Interval. P significant at <0.005 Predictors of COVID-19 vaccine hesitancy: A multivariate analysis Adjusted OR=Adjusted Odds Ratio, CI=Confidence Interval. P significant at <0.005 Discussion VH acts as a major hurdle toward achieving universal vaccination, thereby significantly debilitating the herd immunity of the population. In our study, since the study subjects had been enrolled from the Cowin portal, all the participants had received at least 1 dose of the vaccines available against COVID-19. However, most participants showed considerable VH at some point during the vaccination drive. A greater proportion of VH was found in healthcare workers (30.68% of the total healthcare workers) compared to nonhealthcare workers (25.7% of the total nonhealthcare workers). To date, few studies have investigated acceptance of the COVID-19 vaccines specifically among HCWs, and most published studies assessed VH merely based on refusal to take vaccines.[19202122] A recent study addressing willingness to accept a COVID-19 vaccine among physicians and nurses in France, Belgium, and Quebec, revealed that 48.6% of participants reported high acceptance, whereas 23% reported moderate acceptance, and 28.4% reported hesitancy or reluctance toward the vaccine.[19] A systematic review and meta-analysis done by Wang et al. found the global acceptance and uptake rate of COVID-19 vaccination to be 67.8% and 42.3%.[13] This is a novel study in this regard, as VH can occur or may occur at any point during the vaccination drives. Hence even though all our study subjects have received at least 1 dose of the COVID-19 vaccines, we still analysed their vaccine-seeking behavior in the past before taking the vaccines and tried to understand the factors that contributed toward decreased vaccine uptake. We also focussed on the potential causes of delays that occur during immunization for the first doses as well as subsequent ones. The most important factors that contributed to VH included the fear of the potential long-/short-term side effects of the vaccine followed by the fear of the pain from the shot and distrust in the vaccines due to shorter clinical trials. Other important factors included decision-making was affected due to the large variety of COVID-19 vaccines that became available, and decision-making was affected by views of anti-vaxxer groups on multimedia, social media, family, acquaintances, etc. Based on the findings of our research study, promoting vaccination drives through positive reinforcement signals such as “I am vaccinated” buttons, tags, and social media posts, could prove useful in encouraging vaccine-hesitant groups to eventually consider getting vaccinated. Strengths and limitations of the study Our research sheds light on the potential causes as to why hesitant HCWs decline COVID-19 vaccinations. HCWs, especially family physicians and community health workers, are not only among the first in most jurisdictions to receive vaccinations, but they also serve as role models for the public; as such, their endorsement and acceptance of vaccination eventually persuades reluctant members of society to get vaccinated.[23] Our study has limitations, since it is a cross-sectional study, the changing perspectives of the population that happen longitudinally in time, could not be assessed. A spatiotemporal trend analysis of COVID-19 VH shall prove useful in further understanding the phenomenon. The survey was conducted at a time when COVID-19 vaccination campaigns were at their peak and this may not be reflective of current beliefs. With Aztrazeneca admitting that its vaccine causes thrombosis with thrombocytopenia Syndrome (TTS), VH is bound to multiply fourfold. Furthermore, VH may be context or disease-specific and several models may need to be developed to try and understand the motivations behind VH.[242526] Conclusion India is currently running the world’s largest vaccination drive with a total of 92.58% of its citizens fully vaccinated which is equivalent to 95.09 crores. Our study suggests that even in the presence of adequate vaccination, VH can still exist in the population and can be identified even in subjects seeking vaccination. These findings could prove to be of tremendous value in tailoring communications and promotion campaigns to increase vaccine uptake, specifically with regards to primary care physicians. Evidence-based strategies such as presumptive recommendations, sharing personal endorsements, and motivational interviewing are crucial tools in dissemination of vaccine related information. In short, VH lies on a continuum between vaccine refusal and vaccine acceptance. It is not an “all in or all out” phenomenon which in fact makes its identification and assessment even more difficult.[272829] A comprehensive approach involving multisectoral involvement and ongoing research in the area in order to improve the global coverage of vaccination drives is the need of the hour. Conflicts of interest There are no conflicts of interest.